Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Liver Int. 2019 Oct 7;40(2):416–427. doi: 10.1111/liv.14256

Table 2:

Specific Plasma Metabolites Driving the Differences Between and Within Cohorts from VIP scores in PLS-DA (Q2>0.40).

Turkey vs USA Within Turkey Within USA
Metabolite Control Decomp Control vs comp Ctrl vs decomp Ctrl vs decomp
Lactate (1.34–1.32ppm) -
Lipid CH2 (1.32–1.22ppm)
Lipid CH3 LDL (0.86–0.78ppm) -
Lipid CH3 VLDL (0.92–0.86ppm) -
Glucose (5.25–5.22ppm)
Phosphocholine (3.22ppm) -
↓:

Lower in the group/cohort mentioned first compared to the one mentioned second,

↑:

Higher in the group/cohort mentioned first compared to the one mentioned second,

- :

similar between groups.